The latest closing stock price for Halozyme Therapeutics as of September 18, 2024 is 62.31.
An investor who bought $1,000 worth of Halozyme Therapeutics stock at the IPO in 2004 would have $13,661 today, roughly 14 times their original investment - a 13.64% compound annual growth rate over 21 years.
The all-time high Halozyme Therapeutics stock closing price was 64.42 on August 28, 2024.
The Halozyme Therapeutics 52-week high stock price is 65.53, which is 5.2% above the current share price.
The Halozyme Therapeutics 52-week low stock price is 32.83, which is 47.3% below the current share price.
The average Halozyme Therapeutics stock price for the last 52 weeks is 43.63.
An investor who bought $1,000 worth of Halozyme Therapeutics stock at the IPO in 2004 would have $13,661 today, roughly 14 times their original investment - a 13.64% compound annual growth rate over 21 years.
The all-time high Halozyme Therapeutics stock closing price was 64.42 on August 28, 2024.
The Halozyme Therapeutics 52-week high stock price is 65.53, which is 5.2% above the current share price.
The Halozyme Therapeutics 52-week low stock price is 32.83, which is 47.3% below the current share price.
The average Halozyme Therapeutics stock price for the last 52 weeks is 43.63.